1. Boyle, P.: Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension. Bit J. Clin. Prac., 74: 18–22, 1994.
2. Boyle, P. and Napalkov, P.: The epidemiology of benign prostatic hyperplasia and observations on concomitant hypertension. Scand. J. Urol. Neph., 168, 7–12, 1995.
3. Pool, J.L.: Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia. British Journal of Clinical Practice - Symposium Supplement 74: 13–17, 1994.
4. Pool, J.L: Doxazosin: a new approach to hypertension and benign prostatic hyperplasia. Br. J. Clin. Prac., 50: 154–163,1996.
5. Yalla, S.V., Sullivan, M.P., Lecamwasam, H.S., DuBeau, C.E., Vickers, M.A. and Cravalho, E.G.: Correlation of the American Urological Association symptom index with obstructive and non-obstructive prostatism. J. Urol., 153: 674–680, 1995.